Detalhe da pesquisa
1.
Cost-Effectiveness and Cost-Utility Analyses of Dabigatran Compared with Warfarin in Patients with Nonvalvular Atrial Fibrillation and Risk Factors for Stroke and Systemic Embolism within Brazilian Private and Public Health Care Systems Perspectives.
Value Health Reg Issues
; 8: 36-42, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-29698169
2.
Efficacy of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: one-year follow-up results of the Assessment of the Safety of a New Thrombolytic-3 (ASSENT-3) randomized trial in acute myocardial infarction.
Am Heart J
; 147(6): 993-8, 2004 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-15199346
3.
SBC guidelines on unstable angina and non-ST-elevation myocardial infarction: executive summary.
Arq Bras Cardiol
; 105(3): 214-27, 2015 Sep.
Artigo
em Inglês, Português
| MEDLINE | ID: mdl-26466071